Supernus Pharmaceuticals SUPN Property, plant and equipment at cost
Property, plant and equipment at cost at other companies
Other financials
Where this comes from
Reported directly by Supernus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.
The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's property, plant and equipment at cost.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Supernus Pharmaceuticals's property, plant and equipment at cost?
- Supernus Pharmaceuticals (SUPN) reported property, plant and equipment at cost of $28.8M in Q1 2026.
- How has Supernus Pharmaceuticals's property, plant and equipment at cost changed year-over-year?
- Supernus Pharmaceuticals's property, plant and equipment at cost decreased by 3.3% year-over-year, from $29.78M to $28.8M.
- What is the long-term trend for Supernus Pharmaceuticals's property, plant and equipment at cost?
- Over 4 years (2021 to 2025), Supernus Pharmaceuticals's property, plant and equipment at cost has grown at a -3.6% compound annual growth rate (CAGR), from $33.41M to $28.8M.